Suptavumab Antibody

SKU: orb1980452

Description

Suptavumab (REGN2222) is a human monoclonal antibody that neutralizes respiratory syncytial virus (RSV) by targeting conserved epitopes on subtypes A and B. It is a valuable research tool for studying RSV pathogenesis and evaluating antiviral strategies in both in vitro and in vivo experimental models.

Research Area

Infectious Disease & Virology

Images & Validation

−

Key Properties

−

CAS Number	1629615-23-1
MW	146.04 kDa
Purity	99.2% (SEC-HPLC)
Target	RSV

Bioactivity

−

In Vitro	Suptavumab inhibits the fusion of RSV with cells. It is a human monoclonal antibody targeting the prefusion conformation of the RSV [fusion] glycoprotein and has potent neutralizing activity against RSV group A and RSV group B. Read more...

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

Suptavumab, RSV, REGN2222, REGN-2222, REGN 2222

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Quick Database Links

Gene Symbol

RSV

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols